Eurofins Scientific Past Earnings Performance
Past criteria checks 2/6
Eurofins Scientific has been growing earnings at an average annual rate of 35.4%, while the Life Sciences industry saw earnings growing at 17.6% annually. Revenues have been growing at an average rate of 17.1% per year. Eurofins Scientific's return on equity is 12.5%, and it has net margins of 8.7%.
Key information
35.4%
Earnings growth rate
33.4%
EPS growth rate
| Life Sciences Industry Growth | 17.6% |
| Revenue growth rate | 17.1% |
| Return on equity | 12.5% |
| Net Margin | 8.7% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Eurofins Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 6,712 | 581 | 142 | 0 |
| 30 Sep 22 | 6,785 | 612 | 131 | 0 |
| 30 Jun 22 | 6,857 | 643 | 138 | 0 |
| 31 Mar 22 | 6,787 | 696 | 135 | 0 |
| 31 Dec 21 | 6,718 | 749 | 115 | 0 |
| 30 Sep 21 | 6,553 | 787 | 117 | 0 |
| 30 Jun 21 | 6,388 | 825 | 120 | 0 |
| 31 Mar 21 | 5,913 | 665 | 120 | 0 |
| 31 Dec 20 | 5,439 | 505 | 119 | 0 |
| 30 Sep 20 | 5,079 | 347 | 120 | 0 |
| 30 Jun 20 | 4,719 | 190 | 120 | 0 |
| 31 Mar 20 | 4,641 | 168 | 119 | 0 |
| 31 Dec 19 | 4,563 | 146 | 117 | 0 |
| 30 Sep 19 | 4,384 | 144 | 111 | 0 |
| 30 Jun 19 | 4,205 | 143 | 106 | 0 |
| 31 Mar 19 | 3,993 | 159 | 98 | 0 |
| 31 Dec 18 | 3,781 | 175 | 90 | 0 |
| 30 Sep 18 | 3,549 | 182 | 82 | 0 |
| 30 Jun 18 | 3,318 | 190 | 75 | 0 |
| 31 Mar 18 | 3,145 | 185 | 62 | 0 |
| 31 Dec 17 | 2,971 | 179 | 48 | 0 |
| 30 Sep 17 | 2,848 | 166 | 42 | 0 |
| 30 Jun 17 | 2,725 | 152 | 35 | 0 |
| 31 Mar 17 | 2,631 | 145 | 37 | 0 |
| 31 Dec 16 | 2,537 | 138 | 38 | 0 |
| 30 Sep 16 | 2,427 | 104 | 35 | 0 |
| 30 Jun 16 | 2,317 | 69 | 32 | 0 |
Quality Earnings: ESF has high quality earnings.
Growing Profit Margin: ESF's current net profit margins (8.7%) are lower than last year (11.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ESF's earnings have grown significantly by 35.4% per year over the past 5 years.
Accelerating Growth: ESF's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ESF had negative earnings growth (-22.4%) over the past year, making it difficult to compare to the Life Sciences industry average (9.6%).
Return on Equity
High ROE: ESF's Return on Equity (12.5%) is considered low.